Provided by Tiger Trade Technology Pte. Ltd.

Dermata Therapeutics Inc

2.37
+0.330016.18%
Post-market: 2.33-0.0381-1.61%16:57 EST
Volume:20.98M
Turnover:58.35M
Market Cap:2.43M
PE:-0.15
High:2.69
Open:2.52
Low:2.22
Close:2.04
52wk High:23.70
52wk Low:1.97
Shares:1.03M
Float Shares:843.40K
Volume Ratio:909.27
T/O Rate:2487.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-16.1955
EPS(LYR):-80.3223
ROE:-203.36%
ROA:-96.45%
PB:0.61
PE(LYR):-0.03

Loading ...

Why Is Dermata Therapeutics Stock Surging Wednesday?

Benzinga_recent_news
·
5 hours ago

Dermata Therapeutics: Strategic Shift and Financial Stability Support Buy Rating

TIPRANKS
·
Nov 26

BRIEF-Dermata Therapeutics Inc Files For Mixed Shelf Of Up To $100 Million

Reuters
·
Nov 25

Dermata Therapeutics files $100M mixed securities shelf

TIPRANKS
·
Nov 25

BRIEF-Dermata Therapeutics terminates license agreement with Villani dated March 31, 2017, says in SEC Filing

Reuters
·
Nov 18

Dermata Therapeutics Inc - Termination Linked to Strategic Shift to Otc Skin Care - SEC Filing

THOMSON REUTERS
·
Nov 18

Dermata Therapeutics : Villani Will Not Be Entitled to Receive Any Further Milestones or Other Payments Due After Termination Date

THOMSON REUTERS
·
Nov 18

Dermata Therapeutics Inc - on Nov 17, Terminates License Agreement With Villani Dated March 31, 2017 - SEC Filing

THOMSON REUTERS
·
Nov 18

BRIEF-Dermata Therapeutics Announces Strategic Pivot To OTC Skin Care - SEC Filing

Reuters
·
Nov 15

Dermata Therapeutics Q3 net loss narrows as R&D expenses fall

Reuters
·
Nov 15

Dermata Therapeutics Inc - to Launch First Otc Acne Kit Mid-2026 - SEC Filing

THOMSON REUTERS
·
Nov 15

Dermata Therapeutics Inc - Announces Strategic Pivot to Otc Skin Care - SEC Filing

THOMSON REUTERS
·
Nov 15

Dermata Therapeutics Announces Strategic Shift to Over-the-Counter Dermatology Market, Plans Mid-2026 Launch of Once-Weekly Acne Kit Featuring Spongilla Technology

Reuters
·
Nov 15

Dermata Therapeutics Q3 EPS $(1.65) Misses $(1.59) Estimate

Benzinga
·
Nov 15

Dermata Therapeutics Increases Stock Offering by $1.79M

TIPRANKS
·
Nov 08

Dermata Therapeutics’ Spongilla Acne Treatment Patent Application Accepted by Australian Patent Office

Reuters
·
Oct 02

Dermata Therapeutics Presents Promising Phase 3 Trial Results

TIPRANKS
·
Sep 17

BUZZ-U.S. STOCKS ON THE MOVE-Potbelly, Joby, Talen Energy

Reuters
·
Sep 11

BUZZ-Dermata Therapeutics climbs on acne product shift

Reuters
·
Sep 10

Dermata Therapeutics Inc - to Prioritize Development, Distribution of Otc Pharmaceutical Dermatology Products

THOMSON REUTERS
·
Sep 10